Hermed Capital

Hermed Capital is a private equity fund specializing in direct investments across the global healthcare industry. The firm strategically allocates capital to pharmaceuticals, medical devices and diagnostics, and medical services sectors. It utilizes extensive industry connections to source exclusive deal opportunities and actively supports portfolio companies by providing operational and technical expertise, aiming to enhance value creation beyond traditional financial engineering.

The firm was established in 2015, originating from a strategic partnership between Fosun Pharmaceutical Group (Fosun Pharma) and SK Group, which served as both general partners and anchor investors. This collaboration was predicated on the insight that combining deep industry knowledge with substantial capital could unlock superior returns from promising healthcare assets worldwide. The firm’s approach leverages this founding premise to identify and nurture growth.

Hermed Capital serves investors seeking focused exposure to the healthcare sector's growth potential, and it partners with innovative healthcare companies in need of both capital and strategic guidance. Its vision is to be a catalyst for growth within the healthcare ecosystem, driving innovation and delivering robust financial performance by fostering the development of critical healthcare solutions for a global market.